Targeting TLR4 alleviates the progression of experimental autoimmune encephalomyelitis by regulating central resident cells and Th1/Th17 cell differentiation.
- DOI
- 10.3389/fimmu.2026.1973420
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1973420,
title = {Targeting TLR4 alleviates the progression of experimental autoimmune encephalomyelitis by regulating central resident cells and Th1/Th17 cell differentiation.},
author = {Du E and Lei K and Deng W and Yang S and Liu Y and Dai J and Lei J and Zhang R and Tao H and Chen H and Sun Y},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1973420},
url = {https://doi.org/10.3389/fimmu.2026.1973420}
}RIS
TY - JOUR TI - Targeting TLR4 alleviates the progression of experimental autoimmune encephalomyelitis by regulating central resident cells and Th1/Th17 cell differentiation. AU - Du E AU - Lei K AU - Deng W AU - Yang S AU - Liu Y AU - Dai J AU - Lei J AU - Zhang R AU - Tao H AU - Chen H AU - Sun Y PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1973420 UR - https://doi.org/10.3389/fimmu.2026.1973420 ER -
APA
E, D., K, L., W, D., S, Y., Y, L., J, D., J, L., R, Z., H, T., H, C., & Y, S. (2026). Targeting TLR4 alleviates the progression of experimental autoimmune encephalomyelitis by regulating central resident cells and Th1/Th17 cell differentiation.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1973420
Source records
- pubmed · retrieved 2026-11-10T12:01:45.102Z